Suchergebnisse - "Dudnik, Elizabeth"

PubPharm (5)

1

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer : A Population-Based Cohort Study

enthalten in: The oncologist | 2023

von Icht, O. | Leader, A. | Batat, E. | +8

2

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data

enthalten in: The oncologist | 2022

von Moskovitz, M. | Dudnik, E. | Shamai, S. | +13

3

Next-generation sequencing in thyroid cancers : do targetable alterations lead to a therapeutic advantage?: A multicenter experience

enthalten in: Medicine | 2021

von Moore, A. | Bar, Y. | Maurice-Dror, C. | +9

4

Efficacy and Safety of ALK Tyrosine Kinase Inhibitors in Elderly Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer : Findings from the Real-Life Cohort

enthalten in: Oncology research and treatment | 2019

von Bedas, A. | Peled, N. | Maimon Rabinovich, N. | +8

5

Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapy

enthalten in: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | 2016

von Dudnik, E. | Siegal, T. | Zach, L. | +6

1
[1]